Memorial University Medical Center | |
4700 Waters Avenue, Savannah, Georgia 31404 | |
(912) 350-3691 | |
Name | Memorial University Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 4700 Waters Avenue, Savannah, Georgia |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 110036 |
NPI Number | 1053824292 |
Organization Name | SAVANNAH HEALTH SERVICES, LLC |
Doing Business As | MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER |
Address | 4700 Waters Ave, Savannah, GA 31404 |
Hospital Type | General Acute Care Hospital |
Phone Number | 912-350-8000 |
News Archive
The American Association of Critical-Care Nurses recently awarded an AACN Impact Research Grant to Margaret "Meg" Campbell, RN, PhD, FAAN, a nationally known expert in hospital-based palliative care and end-of-life issues.
Now, a new study published in the journal JAMA Internal Medicine evaluated the incidence of acute myocarditis and clinical outcomes among adults who received the mRNA vaccine in an integrated health care system in the United States.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from CNAO Foundation (Centro Nazionale di Adroterapia Oncologica) in Pavia, Italy.
› Verified 4 days ago
NPI Number | 1326275249 |
Organization Name | MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER |
Address | 4700 Waters Ave, Savannah, GA 31404 |
Hospital Type | General Acute Care Hospital |
Phone Number | 912-350-3595 |
News Archive
The American Association of Critical-Care Nurses recently awarded an AACN Impact Research Grant to Margaret "Meg" Campbell, RN, PhD, FAAN, a nationally known expert in hospital-based palliative care and end-of-life issues.
Now, a new study published in the journal JAMA Internal Medicine evaluated the incidence of acute myocarditis and clinical outcomes among adults who received the mRNA vaccine in an integrated health care system in the United States.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from CNAO Foundation (Centro Nazionale di Adroterapia Oncologica) in Pavia, Italy.
› Verified 4 days ago
NPI Number | 1508058181 |
Organization Name | MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER |
Address | 4720 Waters Ave, Savannah, GA 31404 |
Hospital Type | General Acute Care Hospital |
Phone Number | 912-350-8000 |
News Archive
The American Association of Critical-Care Nurses recently awarded an AACN Impact Research Grant to Margaret "Meg" Campbell, RN, PhD, FAAN, a nationally known expert in hospital-based palliative care and end-of-life issues.
Now, a new study published in the journal JAMA Internal Medicine evaluated the incidence of acute myocarditis and clinical outcomes among adults who received the mRNA vaccine in an integrated health care system in the United States.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from CNAO Foundation (Centro Nazionale di Adroterapia Oncologica) in Pavia, Italy.
› Verified 4 days ago
NPI Number | 1689776841 |
Organization Name | MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER INC. |
Address | 4700 Waters Ave, Savannah, GA 31404 |
Hospital Type | General Acute Care Hospital |
Phone Number | 912-350-8000 |
News Archive
The American Association of Critical-Care Nurses recently awarded an AACN Impact Research Grant to Margaret "Meg" Campbell, RN, PhD, FAAN, a nationally known expert in hospital-based palliative care and end-of-life issues.
Now, a new study published in the journal JAMA Internal Medicine evaluated the incidence of acute myocarditis and clinical outcomes among adults who received the mRNA vaccine in an integrated health care system in the United States.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from CNAO Foundation (Centro Nazionale di Adroterapia Oncologica) in Pavia, Italy.
› Verified 4 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
The American Association of Critical-Care Nurses recently awarded an AACN Impact Research Grant to Margaret "Meg" Campbell, RN, PhD, FAAN, a nationally known expert in hospital-based palliative care and end-of-life issues.
Now, a new study published in the journal JAMA Internal Medicine evaluated the incidence of acute myocarditis and clinical outcomes among adults who received the mRNA vaccine in an integrated health care system in the United States.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from CNAO Foundation (Centro Nazionale di Adroterapia Oncologica) in Pavia, Italy.
› Verified 4 days ago
Candler Hospital Acute Care Hospital Location: 5353 Reynolds Street, Savannah, Georgia 31412 Phone: (912) 819-6000 | |
Memorial University Medical Center Acute Care Hospital Location: 4700 Waters Avenue, Savannah, Georgia 31404 Phone: (912) 350-3691 | |
St Joseph's Hospital - Savannah Acute Care Hospital Location: 11705 Mercy Boulevard, Savannah, Georgia 31419 Phone: (912) 819-4100 | |
Coastal Harbor Treatment Center Psychiatric Hospital Location: 1150 Cornell Ave, Savannah, Georgia 31406 Phone: (912) 354-3911 | |
Georgia Regional Hosp Savannah Psychiatric Hospital Location: 1915 Eisenhower Drive, Savannah, Georgia 31416 Phone: (912) 356-2045 |